chuminhua2020-06-01 20:30
5/30,Menlo Therapeutics公司$Menlo Therapeutics(MNLO)$ 宣布,美国FDA已批准其全资子公司Foamix Pharmaceuticals开发的米诺环素局部疗法Zilxi(1.5% minocyline,FMX103)上市,治疗酒渣鼻成人患者。新闻稿指出,Zilxi是首款获得美国FDA批准治疗酒渣鼻成人患者的米诺环素局部疗法。Zilxi是该公...查看全文
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-020934 Size: 10 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020935 Size: 7 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020659 Size: 5 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020660 Size: 5 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020663 Size: 13 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020656 Size: 5 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020657 Size: 5 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-20-032148 Act: 34 Size: 146 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018220 Size: 6 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-018221 Size: 13 KB 网页链接